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Edited by Masayuki MiyasakaAbstract Studies of stromal cell populations in lymphoid tissue
(LT) have been hampered by a lack of selective markers. Here,
we show that CD248 (Endosialin/TEM1) is a stromal marker
that is diﬀerentially expressed on ﬁbroblasts and pericytes in
the thymus, lymph node and spleen. Expression is high during
LT development but largely disappears in the adult. CD248 is
re-expressed in a Salmonella-induced model of splenic enlarge-
ment; peak expression corresponding to the peak of splenic
enlargement. These results suggest that CD248 expression helps
deﬁne a subset of LT stromal cells which play a role in remodel-
ling during tissue development, infection and repair.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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During the early stages of an immune response, large num-
bers of lymphocytes are recruited into lymphoid tissues where
they are supported by an extensive network of stromal cells [1].
Very little is known about how these stromal cells are regu-
lated, what factors drive their expansion, diﬀerentiation and
survival, and whether they change phenotype during lymphoid
tissue (LT) development as well as following episodes of infec-
tion and immune challenge.
As the major cellular constituent of LT stoma, ﬁbroblasts
not only produce extracellular matrix (ECM) but also have
the ability to remodel tissues following episodes of inﬂamma-
tion [2]. There is increasing evidence that stromal cells play
an important role in the development, organization and func-
tion of LTs in both health and disease [3–6].
Recent studies have provided compelling evidence to sup-
port the concept of regional identity programmed within the
gene expression patterns of ﬁbroblasts, thereby providing a
molecular basis for the predilection of certain cancers andAbbreviations: LT, lymphoid tissue
*Corresponding author. Fax: +44 (0) 121 414 6794.
E-mail address: c.d.buckley@bham.ac.uk (C.D. Buckley).
1These authors contributed equally to this manuscript.
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.06.063chronic inﬂammatory diseases to localize to certain tissue sites
[7]. However, further investigations into the function of ﬁbro-
blasts have been hampered by the lack of ﬁbroblast selective
markers.
By raising a panel of monoclonal antibodies directed
against ﬁbroblast cell surface proteins, we identiﬁed CD248
(Endosialin/TEM-1) as a ﬁbroblast and pericyte marker
[8,9]. In peripheral tissues such as the skin and brain,
CD248 expression varies anatomically and is temporally reg-
ulated with high expression in the embryo and new born tis-
sues [9,10]. CD248 is a new member of a family of molecules
that includes CD93 and CD141; two molecules implicated in
tissue remodelling and repair [11,12]. In keeping with a poten-
tial role in tissue remodelling, CD248 is expressed on ﬁbro-
blasts and pericytes in human inﬂammatory and cancer
stroma [13]. These data have been supported by the recent
publication of the phenotype of mice deﬁcient in CD248
[14]. Whereas growth and progression of tumours implanted
into the skin were unaﬀected by the absence of CD248, there
was reduced tumour growth, invasiveness and metastasis after
transplantation into abdominal sites in CD248/ mice. The
molecular basis for these ﬁndings remains unclear but defects
in the size of blood vessels in the CD248/ mice were ob-
served.
In this study, we have assessed the expression of CD248 in
mouse LTs during development and in the spleen following
infection with an attenuated strain of Salmonella enterica sero-
var Typhimurium (abbreviated to Salmonella throughout) [15].
We have found that CD248 expression correlates with
the stage of LT development and following Salmonella infec-
tion, CD248 expression increases and decreases in phase
with expansion and contraction of the spleen. Taken together
our ﬁndings suggest that CD248 can be used as a marker of
a novel subset of ﬁbroblasts that regulate expansion,
remodelling and repair of LT during embryogenesis and
inﬂammation.2. Materials and methods
2.1. Mice and tissue sectioning
Wild type C57Bl/6 mice were obtained from the BMSU, University
of Birmingham, UK or Harlan UK Limited, Oxford, UK. All experi-
ments were performed in accordance with UK laws and with the ap-
proval of the local ethics committees. At each developmental stage,
mice were killed and LTs, spleen, thymus and lymph nodes (axillary,
cervical and mesenteric) excised. Intact organs were then snap frozenblished by Elsevier B.V. All rights reserved.
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of all excised LTs were prepared, ﬁxed in 100% acetone at 4 C for
20 min, dried and stored at 80 C.
2.2. Indirect immunoﬂuorescence staining and confocal microscopy
Indirect immunoﬂuorescence was performed using the following
antibodies: anti-CD248 P13 (generated in our laboratory [9]). From
eBiosciences; anti-CD3-FITC, anti-VCAM-1-biotin (clone 429), anti-
CD31-FITC, anti-CD11c-FITC, anti-B220-FITC. From Southern
Biotech; anti-VCAM-1-biotin (clone MK2). From Serotec; anti-F4/
80-FITC. From Jackson ImmunoResearch; anti-rabbit Cy5, anti-
Armenian hamster Cy2, anti-biotin TRITC. From Molecular Probes;
SA-alexa 488, anti-FITC alexa 488. From Zymed; anti-rat Cy3. From
Vector; anti-hamster biotin. Anti-ER-TR7 a kind gift fromWillem van
Ewijk. Anti-gp38 a kind gift from Andy Farr. A Zeiss confocal LSM
510 microscope (Zeiss, Germany) was used to visualize staining with
images captured and processed using the Zeiss LSM Image Examiner
software (Zeiss). Representative images were chosen from each exper-
iment for ﬁgure editing.
2.3. Salmonella infections
The attenuated Salmonella enterica serovar Typhimurium SL3261
was used to immunize adult (9-week-old) C57Bl/6 mice as previously
described [16].
2.4. Mean ﬂuorescent intensity (MFI)
The MFI for each stromal marker was calculated using the Zeiss
LSM Image Examiner software (Zeiss) by analysing the total ﬂuores-
cent intensity (intensity · absolute frequency) divided by the total
number of pixels per image. Five images were analysed per time point
and the standard deviation of each data set plotted. Statistical analysisFig. 1. Temporal expression of CD248 in lymphoid organs. CD248 express
spleen (A), thymus (B) and lymph nodes (C) co-stained with CD3 (grey). Imwas carried out using GraphPad Prism computer software (GraphPad
Software, Inc., San Diego, CA) and performing ANOVA followed by
a Tukey’s multiple comparisons test.3. Results
3.1. Dynamic expression of CD248 during lymphoid tissue
development
To analyse the temporal expression of CD248 in mouse LTs,
spleen, thymus and lymph nodes (LN) were excised at several
developmental stages: embryonic (day 16), new born (day 2)
and adult (weeks 2 and 6). Tissues were co-stained with a rab-
bit anti-mouse polyclonal antibody speciﬁc to CD248 (P13)
which we have previously validated [8] and CD3 to visualize
T-cell areas within the LTs (Fig. 1). CD248 expression was ob-
served throughout the prenatal spleen, with expression becom-
ing more restricted to the red pulp as the white pulp areas
matured with age (Fig. 1A). In the adult spleen (week 6)
expression of CD248 on interstitial ﬁbroblasts in the red pulp
decreased, with expression of CD248 predominantly on vascu-
lar-like cell. In contrast, E16 thymic expression of CD248 was
conﬁned to developing vascular-like structures within the epi-
thelial medulla and the outer layer of mesenchymal cells
(Fig. 1B). Expression levels of CD248 then decreased in the
postnatal thymus with very little expression observed in adult
thymus. A similar pattern of staining to that of the thymus wasion (green) at developmental stages E16, day 2, week 2 and week 6 in
ages are ·10 magniﬁcation with ·40 insets.
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ﬁned to the outer mesenchymal layers of cells, with expression
expanding throughout the node by day 2 after birth (Fig. 1C).
In adult LN (week 6) expression of CD248 was markedly re-
duced, with expression mainly restricted to vascular like struc-
tures with weak expression on ﬁbroblasts in the interstitial
follicular area of the LN.
3.2. Distinct stromal subsets express CD248 during lymphoid
tissue development
To further deﬁne the stromal cells that express CD248 in
LTs, co-expression of CD248 with endothelial and other stro-
mal cell surface markers was analysed. CD248 expression was
conclusively demonstrated to be non-endothelial by co-stain-
ing of CD248 with the endothelial-speciﬁc marker, CD31
[17] (Fig. 2). In addition, a macrophage marker, F4/80 [18],
dendritic cell marker, CD11c [19] and gp38, a stromal and lym-
phatic endothelial marker [20–22] did not co-localise with
CD248 in any of the LT we examined (data not shown). In
contrast, VCAM-1 and ER-TR7, a marker of reticular ﬁbro-
blasts [23], were found to subdivide the CD248 expressing pop-
ulations. We therefore examined how these subpopulations
changed during LT development (Fig. 3). In E16 spleen,
CD248 was observed to be the only stromal-speciﬁc protein ex-
pressed; expression of VCAM-1 and ER-TR7 only emerging in
the post natal period (Fig. 3A). Major populations of CD248/
VCAM-1 and CD248/ER-TR7, with a minor CD248/VCAM-Fig. 2. CD248 expression on interstitial ﬁbroblasts and pericytes in lymphoi
stages E16, day 2, week 2 and week 6 in spleen (A), thymus (B) and lymph1/ER-TR7 population were observed in the interstitial ﬁbro-
blast compartment with only very small populations of single
positive CD248 expressing cells by day 2. VCAM-1 expression
was further up-regulated by week 2, and by week 6 the pre-
dominant populations observed in the spleen were single posi-
tive ER-TR7 or VCAM-1 cells within the red pulp of the
tissue.
In contrast to the spleen, E16 thymic CD248 populations co-
expressed ER-TR7 in the epithelial medulla and surrounding
mesenchyme (Fig. 3B). In addition, VCAM-1 expression was
restricted to a population of epithelial stromal cells that did
not co-localize with either CD248 or ER-TR7. Postnatal pop-
ulations of CD248 positive cells in the thymus were also largely
ER-TR7 positive, with these being the only dominant subpop-
ulation remaining in the adult thymus by week 6.
Similar to the embryonic thymus, CD248 expressing cells in
E16 LN were also entirely ER-TR7 positive with VCAM-1
expression low and largely conﬁned to the inner medulla
(Fig. 3C). As the LN develops stromal heterogeneity increased
and by week 2 the expression of VCAM-1 was reduced with
the double positive, CD248/ER-TR7 population the most
prominent population. By week 6, VCAM-1 expression re-
mained low, the vascular CD248/ER-TR7 population was
maintained in the medulla and CD248 expression persisted
in a small single positive population within the B cell follicular
zone. Given the reported diﬀerences between T cell ﬁbroblastic
reticular cell (FRC) and B cell ﬁbroblastic dentritic cell (FDC)d organs. CD248 (green) and CD31 (red) expression at developmental
nodes (C). Images are ·10 magniﬁcation with ·40 insets.
Fig. 3. Temporal expression of CD248/VCAM-1/ER-TR7 stromal cell populations in lymphoid organs. CD248 (green), VCAM-1 (red) and ER-TR7
(blue) stromal populations at developmental stages E16, day 2, week 2 and week 6 in spleen (A), thymus (B) and lymph nodes (C). Images are ·10
magniﬁcation with ·40 insets.
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investigations to analyse whether CD248 is diﬀerentially ex-
pressed on these two diﬀerent stromal cell subsets.
3.3. Dynamic expression of CD248 during remodelling and
repair in the spleen
Following immunization of adult C57Bl/6 mice with Salmo-
nella the spleen enlarges dramatically; up to 15 times the aver-
age resting state weight [15]. Inﬂammation is well established
at day 4 with the peak expansion occurring between day 11
and day 21 post infection. Resolution follows, which although
never complete, returns the spleen to near normal starting
weight by day 35. The distribution of lymphocytes duringFig. 4. Expression of CD248 compared to B cell populations (B220) during
stromal populations were examined following Salmonella infection of the spl
Images are ·10 magniﬁcation.the remodelling of the spleen in Salmonella infection is com-
plex and still currently under investigation [15]. To examine
whether CD248 might play a role in this remodelling and to
compare its expression to B cells within the B cell area of the
spleen we examined the expression of CD248 and B220 (B cell
marker) [25] during Salmonella infection of the spleen (Fig. 4).
A pronounced enrichment of CD248 expressing cells was ob-
served within the red pulp of the spleen which coincided with
a transient shrinkage of the B cell area in the white pulp.
To further explore whether CD248 and its stromal cell sub-
populations also changed during Salmonella infection of the
spleen, we examined the expression of CD248/VCAM-1/ER-
TR7 following infection. A pronounced enrichment ofsplenic remodelling and repair. B220 (red) B cell and CD248 (green)
een at day 0 (A), day 4 (B), day 12 (C) and day 35 (D) post injection.
Fig. 5. Expression of CD248 stromal populations during splenic remodelling and repair. CD248 (green), VCAM-1 (red) and ER-TR7 (blue) stromal
populations during Salmonella infection of the spleen at day 0 (A), day 4 (B), day 12 (C) and day 35 (D) post injection. Images are ·10 magniﬁcation.
3554 S. Lax et al. / FEBS Letters 581 (2007) 3550–3556CD248 and VCAM-1 expressing cells was observed during the
early phase (day 4) of Salmonella infection. In contrast, the
expression of ER-TR7 was reduced (Fig. 5A and B). This trend
was emphasised further still as inﬂammation and remodelling
of the spleen reached its peak (day 12) (Fig. 5C). Strikingly
at this time point, and concomitant with a change of the sple-
nic architecture so that the white and red pulp areas are almost
indistinguishable, CD248, VCAM-1 and CD248/VCAM-1
expressing cells were present throughout the whole of the in-
fected spleen. Unexpectedly, the expression of ER-TR7 fell
to levels approaching zero. Following resolution (day 35),
the architecture of the spleen returned to that resembling the
pre-infected state with the expression patterns of all three stro-
mal markers restored to near pre-infected levels (Fig. 5D).
These changes in expression of CD248, VCAM-1 and ER-
TR7 were quantiﬁed by measuring the MFI of each stromal
marker at each phase (Fig. 6).4. Discussion
In a previous study, we identiﬁed CD248 as a ﬁbroblast and
pericyte restricted marker in peripheral tissues such as the skin
and brain [8]. Using this stromal marker we report here that
CD248 is a marker of mouse LT stroma and is expressed on
both interstitial ﬁbroblasts and pericytes. CD248 expression
is dynamically regulated during development; strongly ex-
pressed in embryonic spleen, thymus and LNs yet down-regu-lated during post natal development. While this expression
pattern has previously been observed in a range of other tissues
[9,10], and is therefore likely to reﬂect a common developmen-
tal programme of CD248 expression, we noted distinct ana-
tomical diﬀerences in the topographic expression of CD248
between the diﬀerent LT with the thymus and LN more closely
resembling each other than the spleen.
We also found that changes in the expression of CD248,
when combined with two well-deﬁned LT stromal markers
(VCAM-1 and ER-TR7) help to deﬁne discreet CD248 sub-
populations, which also varied signiﬁcantly between the
spleen, thymus and LN. These results suggest that such site
speciﬁc diﬀerences in expression of CD248, VCAM-1 and
ER-TR7 on stromal cell subsets in the diﬀerent LTs may con-
tribute to their distinctive immunological functions.
The immune response to Salmonella involves splenomegaly
which is associated with complete remodelling of the architec-
ture within the spleen [15]. We observed a signiﬁcant increase
in CD248 expression as the spleen increased in weight. At peak
weight, the expression of CD248 was so ﬂorid that there were
very few CD248 negative areas. As inﬂammation resolved,
CD248 expression decreased although it still remained slightly
higher than that observed pre-infection. This possibly reﬂects
incomplete resolution within this model, although could also
reﬂect subtle diﬀerences within the stromal cell compartment
following an immune challenge.
Although VCAM-1 expression closely mirrored that of

































Days post salmonella infection
Fig. 6. Quantiﬁcation of stromal marker expression during splenic remodelling and repair. The MFI of each stromal marker, CD248 (green),
VCAM-1 (red) and ER-TR7 (blue), was calculated during Salmonella infection of the spleen (days 0, 4, 12, and 35). Error bars represent one standard
deviation from the mean *P < 0.05, **P < 0.01 and ***P < 0.001.
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lapse. One possible explanation might be active degradation
of the ER-TR7 epitope by proteases. It is tempting to implicate
metalloproteinases (MMP) given that they have been reported
to be key modulators in many relevant pathophysiological
processes including angiogenesis [26], wound healing [27] and
inﬂammation [28]. It will now be of interest to investigate
the expression and activity of MMP family members during
the Salmonella model of remodelling and to test whether
CD248 can directly regulate MMP expression and function
in the cells that express it.
A number of unanswered questions remain concerning the
regulation of CD248 expression on stromal cell populations in
LTs. Do similar increases in the expression of CD248 occur fol-
lowing Salmonella infection, or indeed any other inﬂammatory
response in lymph nodes? Are the changes in CD248 expression
a result of de novo expression/re-expression on tissue resident
cells or from the recruitment and/or emigration of CD248-
expressing cells from the peripheral circulation? Does the in-
verse relationship between CD248/VCAM-1 and ER-TR7
expression during splenic remodelling reﬂect distinct functional
phases during spenomegaly? Isolating these distinct subsets and
examining how splenomegaly is altered in CD248 deﬁcient mice
will begin to address how CD248 expressing subsets contribute
to the dramatic changes that occur in lymphoid microenviron-
ments during development and following immune responses.
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